Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | TPMT | P51580 | 1/20 | 0.31 |
| ▸ | ACHE | P22303 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | PRKDC | P78527 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4808079 | 0.75 | ALDH1A1 (0.32) | TDP1ALDH1A1 | |
| SCHEMBL10313767 | 0.71 | TSHR (0.34) | TDP1ALDH1A1ACHECYP3A4HSD17B10 | |
| SCHEMBL10957409 | 0.68 | HSPB1 (0.47) | TDP1ALDH1A1L3MBTL1MAPT | |
| SCHEMBL10957637 | 0.67 | — | — | |
| SCHEMBL17465776 | 0.67 | THRB (0.31) | — | |
| SCHEMBL14915895 | 0.66 | TPMT (0.32) | TPMT | |
| SCHEMBL18950021 | 0.62 | — | — | |
| SCHEMBL14387614 | 0.62 | VCAM1 (0.36) | ALDH1A1HTTMAPT | |
| SCHEMBL18567142 | 0.62 | KMT2A (0.33) | ALDH1A1CYP3A4MAPT | |
| SCHEMBL18929869 | 0.61 | HTR1D (0.30) | ACHEHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2015069110-A1 | MULTIPLE D2 A(NTA)GONISTS/H3 ANTAGONISTS FOR TREATMENT OF CNS-RELATED DISORDERS | AAPA B.V. (NL) | 2015-05-14 | — | — | WO | disclosed |